eTrialTrackTeleHealth designed around Delhi's clinical research ecosystem
Connect study teams, research sites and participants with practical support appropriate remote study interactions suited to the scale and complexity of clinical research in Delhi.
Clinical Research Context in Delhi
Delhi/NCR is one of India’s largest clinical-research markets. The source register snapshot lists 332 studies with New Delhi sites. AIIMS New Delhi operates a Clinical Research Unit and documents clinical-trial and translational-research activity. The source also identifies Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research as part of the research ecosystem. Clinical research activity changes over time, so this page uses a September 2026 snapshot as market context rather than a permanent study count.
The wider Delhi clinical-research ecosystem includes AIIMS New Delhi, Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research. These organizations are cited as examples of the local research environment and are not eTrialTrack customers unless a documented customer relationship exists.
How Can TeleHealth Support Clinical Trials in Delhi?
For organizations operating in Delhi, the relevant technology question is not simply whether a digital platform is available, but whether it can support the operational requirements of the study. eTrialTrack TeleHealth can be evaluated for workflows involving high-volume tertiary research, oncology and complex studies, participant tracking, electronic data capture and remote participant workflows. The product is designed to provide support appropriate remote study interactions through scheduled video consultations, participant interaction, documentation and connected workflow visibility. The exact configuration should be determined by protocol requirements, organizational procedures, user roles, integrations and implementation scope.
Why Consider eTrialTrack?
Organizations in Delhi can evaluate eTrialTrack TeleHealth when they need a practical workflow that can be configured around their study rather than a generic process. Relevant product capabilities include Scheduled Video Consultations; Remote Participant Interaction; Investigator Interaction; Appointment-Based Workflows; Documentation; Connected Study Operations; Remote Workflow Visibility. Where appropriate, the module can connect with other eTrialTrack capabilities to create a more coherent participant, site and data workflow.
A Practical Local Implementation Approach
A typical discussion for a Delhi study can begin with study requirements, participant and site workflows, data responsibilities, user roles, integrations, implementation timelines and support expectations. From there, the relevant eTrialTrack capabilities can be configured and evaluated against the study requirements.
Local Research Ecosystem
AIIMS New Delhi, Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research. These names describe the broader market context only and should not be presented as customers, partners or users of eTrialTrack without documented evidence.
Important Scope
eTrialTrack TeleHealth is a technology capability, not a substitute for the approved protocol, investigator responsibilities, ethics requirements, applicable regulations, quality procedures or clinical judgment. Product suitability should be assessed against the specific study and documented requirements.
Who uses eTrialTrack TeleHealth in Delhi
For research teams in Delhi, the TeleHealth module fits specific roles and study situations — here's who it serves, what it supports, and when to adopt it.
- Pharmaceutical companies and CROs operating in Delhi
- Investigator sites and hospitals across Delhi's research ecosystem
- Sites conducting remote or hybrid study visits
- Participants who cannot travel for every assessment
- Secure video consultations inside the study workflow
- Hybrid visit schedules mixing on-site and remote touchpoints
- Remote follow-ups that keep retention high between site visits
- When travel burden is your top dropout driver
- When protocols add decentralized elements mid-study
- When you want local implementation support — onboarding and training aligned to IST, wherever your sites are
Video Consultation Module for Clinical Trials in Delhi — frequently asked questions
What does the Video Consultation Module for Clinical Trials do for Delhi clinical trials?
eTrialTrack TeleHealth is designed as a study-enablement component for protocols that permit remote interactions. It can support scheduled video consultations and participant interactions while connecting relevant information to the broader study workflow.
Is the TELEHEALTH module compliant for Delhi-based studies?
Yes — eTrialTrack is FDA 21 CFR Part 11, ICH-GCP, HIPAA and GDPR compliant, with complete audit trails and e-signatures accepted by Indian (CDSCO) and global regulators.
How quickly can our Delhi team deploy the Video Consultation Module for Clinical Trials?
Most teams go live in 2-4 weeks, including configuration, validation support and team training in IST.
Can we get a Delhi demo of the TELEHEALTH module?
Absolutely — book a 30-minute guided walkthrough and we will tailor it to your Delhi study setup and protocols.